PCR Testing in Minutes with Digital Microfluidics

According to the CDC, the “gold standard” for SARS-CoV-2 testing is reverse transcription polymerase chain reaction (or RT-PCR). Digital microfluidics enables ultra-rapid PCR results by utilizing low droplet volume with built-in heaters and sensors on cartridge.

Founders’ Report 2020

We express our deepest gratitude to the professionals in public health and medical labs during a tumultuous year with the raging pandemic. At Baebies, we are grateful to have multiple major milestones to celebrate as we reflect on 2020. See our annual Founder’s Report.

Baebies Wins the 2020 AACC Disruptive Technology Award

Baebies was selected as the winner of the AACC Disruptive Technology Award by a panel of expert judges at the #2020AACC Annual Meeting. During the virtual competition, Baebies presented FINDER®, a diagnostic platform featuring a toaster-sized instrument and disposable cartridge.

5 Things to Know about Testing with Digital Microfluidics

Digital microfluidics (DMF) technology is a method to programmably manipulate tiny droplets of liquid by electrical control of surface tension (or electrowetting) to perform tests on a disposable cartridge. Learn the unique benefits that DMF brings to diagnostic testing and newborn screening.

Baebies Selected as Finalist for the 2020 AACC Disruptive Technology Award

Baebies has been named a finalist for the 2020 American Association for Clinical Chemistry’s (AACC) Disruptive Technology Award for FINDER®, a near-patient testing platform. As a growth-stage company developing diagnostic products to provide a healthy start for children everywhere, Baebies FINDER tests for diseases from low blood volume (50 µL) with a turn-around time of approximately 15 minutes after sample introduction.

Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses

This peer-reviewed publication focuses on the development and practical experience of using digital microfluidic fluorometry (DMF) to screen newborns for MPS I in the USA, as published in the International Journal of Neonatal Screening (2020). Preliminary results of NBS for MPS II and MPS III using DMF are discussed.